155 related articles for article (PubMed ID: 29772242)
1. Synthesis, molecular modeling and biological evaluation of potent analogs of 2-methoxyestradiol.
Al-Kazaale N; Tran PT; Haidari F; Solum EJ; Liekens S; Vervaeke P; Sylte I; Cheng JJ; Vik A; Hansen TV
Steroids; 2018 Aug; 136():47-55. PubMed ID: 29772242
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of new 2-methoxyestradiol derivatives: Potent inhibitors of angiogenesis and tubulin polymerization.
Sun M; Zhang Y; Qin J; Ba M; Yao Y; Duan Y; Liu H; Yu D
Bioorg Chem; 2021 Aug; 113():104988. PubMed ID: 34034135
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site.
Cushman M; He HM; Katzenellenbogen JA; Lin CM; Hamel E
J Med Chem; 1995 Jun; 38(12):2041-9. PubMed ID: 7783135
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, cytotoxic effects and tubulin polymerization inhibition of 1,4-disubstituted 1,2,3-triazole analogs of 2-methoxyestradiol.
Solum EJ; Vik A; Hansen TV
Steroids; 2014 Sep; 87():46-53. PubMed ID: 24923521
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors.
Khelifi I; Naret T; Renko D; Hamze A; Bernadat G; Bignon J; Lenoir C; Dubois J; Brion JD; Provot O; Alami M
Eur J Med Chem; 2017 Feb; 127():1025-1034. PubMed ID: 28166995
[TBL] [Abstract][Full Text] [Related]
6. Advance of 2-methoxyestradiol as a promising anticancer agent for cancer therapy.
Ba M; Duan Y
Future Med Chem; 2020 Feb; 12(4):273-275. PubMed ID: 31983223
[No Abstract] [Full Text] [Related]
7. Design, Synthesis, and Evaluation of Novel 2-Methoxyestradiol Derivatives as Apoptotic Inducers Through an Intrinsic Apoptosis Pathway.
Sheng LX; Zhang JY; Li L; Xie X; Wen XA; Cheng KG
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31936880
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and molecular docking studies of a new series of chalcones containing naphthalene moiety as anticancer agents.
Wang G; Qiu J; Xiao X; Cao A; Zhou F
Bioorg Chem; 2018 Feb; 76():249-257. PubMed ID: 29197743
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents.
Yang J; Yang S; Zhou S; Lu D; Ji L; Li Z; Yu S; Meng X
Eur J Med Chem; 2016 Oct; 122():488-496. PubMed ID: 27423028
[TBL] [Abstract][Full Text] [Related]
10. New indole-based chalconoids as tubulin-targeting antiproliferative agents.
Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S
Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y
Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluations of new analogs of 2-methoxyestradiol: inhibitors of tubulin and angiogenesis.
Solum EJ; Cheng JJ; Sørvik IB; Paulsen RE; Vik A; Hansen TV
Eur J Med Chem; 2014 Oct; 85():391-8. PubMed ID: 25108078
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
Ramya PVS; Guntuku L; Angapelly S; Digwal CS; Lakshmi UJ; Sigalapalli DK; Babu BN; Naidu VGM; Kamal A
Eur J Med Chem; 2018 Jan; 143():216-231. PubMed ID: 29174816
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of 2-phenylquinoline-4-carboxamide derivatives as a new class of tubulin polymerization inhibitors.
Zhu L; Luo K; Li K; Jin Y; Lin J
Bioorg Med Chem; 2017 Nov; 25(21):5939-5951. PubMed ID: 28988750
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and molecular modeling of new 4-phenylcoumarin derivatives as tubulin polymerization inhibitors targeting MCF-7 breast cancer cells.
Batran RZ; Kassem AF; Abbas EMH; Elseginy SA; Mounier MM
Bioorg Med Chem; 2018 Jul; 26(12):3474-3490. PubMed ID: 29793751
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties.
Diao PC; Li Q; Hu MJ; Ma YF; You WW; Hong KH; Zhao PL
Eur J Med Chem; 2017 Jul; 134():110-118. PubMed ID: 28410492
[TBL] [Abstract][Full Text] [Related]
19. Combretastatin linked 1,3,4-oxadiazole conjugates as a Potent Tubulin Polymerization inhibitors.
Kamal A; Srikanth PS; Vishnuvardhan MV; Kumar GB; Suresh Babu K; Hussaini SM; Kapure JS; Alarifi A
Bioorg Chem; 2016 Apr; 65():126-36. PubMed ID: 26943479
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin.
Romagnoli R; Baraldi PG; Salvador MK; Prencipe F; Lopez-Cara C; Schiaffino Ortega S; Brancale A; Hamel E; Castagliuolo I; Mitola S; Ronca R; Bortolozzi R; Porcù E; Basso G; Viola G
J Med Chem; 2015 Apr; 58(7):3209-22. PubMed ID: 25785605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
